Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Pharma
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
A phase 3 study has shown that AZ and Amgen's Tezspire worked in patients with severe chronic rhinosinusitis with nasal polyps.
Kevin Dunleavy
Nov 8, 2024 3:31pm
AstraZeneca backs campaign to improve lives of COPD patients
Nov 4, 2024 10:40am
AstraZeneca's new TV spot for COPD drug Breztri sets sail
Oct 22, 2024 7:35am
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
Sep 27, 2024 9:40am
GSK posts COPD win for Nucala as rival nears possible approval
Sep 6, 2024 9:40am
FDA delays decision on Sanofi and Regeneron's Dupixent for COPD
May 31, 2024 9:30am
